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Background: Thewatershed of Dez andKaroon rivers located in
iddle Zagrous mountain with area about 68481-km, thus water-
hed is a part of Persian gulf watershed. Cholera, an acute intestinal
nfection caused by the bacterium Vibrio cholerae, is a historically
eared epidemic diarrheal disease that remains a major public
ealth problem in many parts of Africa, Asia, and Latin America.
ibrio cholerae O1 exists as two major serotypes, Inaba and Ogawa,
member of the family Vibrionaceae. Vibrio cholerae is transmit-
ed through freshwater contaminatedwith fecalmatter. Foodborne
nfections have been traced to rawor inadequately cooked shellﬁsh
nd other seafood. The target of study the segregate Vibrio cholerae
1 (Vibrionaceae) in the Karun Ahvaz river.
Methods: In four stages (April, May, June and July 2010), a total
00 samples ofwater fromKaroonRiverAhvazwere collected. Dur-
ng the study period the recorded river temperature was about
5-28(C and pH ranged from 7 to 8. Swabs were cultured onto
hiosulphate citrate bile sucrose and MacConkey, and morphologi-
al colonies compatible with Vibrio were characterized by oxidase
est and agglutinated with antiserum (Difco, Detroit, MI, USA) for
erotype determination. Also V. cholerae biochemical tests with API
0E (BioMerieux, Marcy-l’Etoile, France).
Results: From100 samples ofwater Karoon River in Ahvaz, Iran,
(8%) sample were positive for Vibrio cholerae strains. The isolated
trains fromwater KaroonRiver inAhvaz, Iran,wereVibrio cholerae
1 (inaba).
Conclusion: The priorities for cholera control remain pub-
ic health interventions through improved water and sanitation,
mproved surveillance and access to health care facilities, and fur-
her development of appropriate vaccines.
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Background: Infection represents one of the primary barriers
to successful organ transplantation and an early diagnosis repre-
sent the goal of therapy. Our principal end point was to use a new
assay Test EAA which has been developed to rapidly detect endo-
toxin acivity. Furthermore we aim to prove the validity and safety
of removal of endotoxins using Polymyxin-B based hemoperfusion
(PMX-DHP).
Methods: The criteria for inclusion in the studywere the follow-
ing ﬁndings: infection was suspected when patients had at least
2 of the 4 criteria of systemic inﬂammatory response syndrome
(SIRS). Following these criteria, the Test EAA was performed on
71 patients (29 liver transplant and 42 kidney transplant). Twenty
eight patients(39,5%) with EA>0.60 were enrolled in this study
and received treatment to remove endotoxins (PMX-DHP). Each
treatment was performed for two hours with a blood ﬂow rate of
100mL/min. All the patients were treated with PMX-DHP until an
EA<0.4 was found.
Results: No relevant adverse events were observed during the
72 treatments performed.Before performing PMX-DHP treatments,
the median EA was 0.81(range 0.62-1.25) and 0.73(range 0.61-
0.98) in liver and kidney transplant patients respectively. In liver
transplant patients two PMX-DHP treatments were performed on
7 patients [median EA =0.69(0.62-0.76)], three treatments on 4
patients[median EA =0.84(0.77-0.91)] and four treatment on 3
patients [median EA =1.11(0.95-1.25)]. At the end of the endo-
toxin removal therapy, the median EA level was 0.33[0.22-0.4].The
stabilization of hemodynamic and inﬂammatory frameworks were
observed after the PMX-DHP.At 30 days of follow up all patients
were alive with a good graft function and low level of endotoxin
activity.
Conclusion: Given the progress achieved and considering the
particular difﬁculties in the diagnosis of transplant patients, we
think that might be useful to determine the endotoxin activity
routinely in these patients. Accordingly, larger multicenter clini-
cal trials will be necessary to accurately assess the beneﬁts of EA
essay plus DHP-PMX for transplant patients with endotoxemia and
suspect of infection.
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